过去一年中添加的文章，按日期排序
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled Trial
D Ciardiello, E Martinelli, T Troiani, G Mauri… - JAMA Network …, 2024 - jamanetwork.com
57 天前 - … Treatment with anti–epidermal growth factor receptor (… is poor, because it has been
mainly derived via post hoc analysis … -associated rechallenge with EGFR inhibitors could be …
mainly derived via post hoc analysis … -associated rechallenge with EGFR inhibitors could be …
Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
J Schachenhofer, VE Gruber, SV Fehrer… - Neuropathology and …, 2024 - Wiley Online Library
57 天前 - … We focused on the epidermal growth factor receptor (EGFR) … -derived SEGA cell
lines showed that afatinib treatment had a … that EGFR inhibition via afatinib treatment might be a …
lines showed that afatinib treatment had a … that EGFR inhibition via afatinib treatment might be a …
[HTML][HTML] EVALUATION OF POTENTIAL PEPTIDE INHIBITORS THAT INTERACT WITH THE EGF RECEPTOR. RELEVANCE TO GLIOBLASTOMA
LM Mendes, DV Sobral, ÉV dos Santos… - … and Cell Therapy, 2024 - Elsevier
57 天前 - … and block of epidermal growth factor receptor (EGFr) signaling. … Anti-EGFr-LP and
anti-EGFr-LG peptides were … Chromatographic analyzes obtained by HPLC confirmed that …
anti-EGFr-LG peptides were … Chromatographic analyzes obtained by HPLC confirmed that …
[HTML][HTML] … SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small …
MG Choi, GW Son, MY Choi, JS Jung… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
62 天前 - … treatment options in patients with osimertinib resistance in epidermal growth factor
receptor (EGFR… Study design and schematic overview of the treatment in the cell line-derived …
receptor (EGFR… Study design and schematic overview of the treatment in the cell line-derived …
Isolation, characterization and pharmacological potentials of methanol extract of Cassia fistula leaves: Evidenced from mice model along with molecular docking …
63 天前 - … of the methanolic crude extract derived from the leaves of … affinity with epidermal
growth factor receptor (EGFR) and … is employed in Ayurvedic medicine for managing diabetes…
growth factor receptor (EGFR) and … is employed in Ayurvedic medicine for managing diabetes…
Deciphering the Impact of Rare Missense Variants in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer through Whole Exome Sequencing: A Computational …
A Balasundaram, GP C Doss - ACS omega, 2024 - ACS Publications
64 天前 - … Targeted therapy revolutionizes the treatment of non-small… Epidermal growth factor
receptor(EGFR) mutations play a … samples with EGFR-TKI-resistant NSCLC obtained from …
receptor(EGFR) mutations play a … samples with EGFR-TKI-resistant NSCLC obtained from …
Exploratory study of predicting systemic therapy response by IGRA in advanced stage NSCLC patients
HC Huang, CL Chiang, YH Luo, YM Chen, CH Chiu - Cancer Research, 2024 - AACR
67 天前 - … immune checkpoint inhibitors (ICI) and epidermal growth factor receptor (EGFR)
Tyrosine … Blood sample from each enrolled patient was obtained for INF-γ release assay (IGRA) …
Tyrosine … Blood sample from each enrolled patient was obtained for INF-γ release assay (IGRA) …
EGFR inhibitors increase LGR5 expression and enhance potency of LGR5 antibody-drug conjugates targeting colorectal cancer stem cells
67 天前 - … treatment withdrawal was a major obstacle. Interestingly, FDA-approved therapy
targeting epidermal growth factor receptor (EGFR… levels in patient-derived models of CRC. This …
targeting epidermal growth factor receptor (EGFR… levels in patient-derived models of CRC. This …
Exploratory analysis using serial cell-free DNA in patients treated with amivantamab in non-small cell lung cancer with EGFR exon 20 insertion mutations
GH Park, S Park, HA Jung, JM Sun, JS Ahn, MJ Ahn… - Cancer Research, 2024 - AACR
67 天前 - … Introduction: Epidermal growth factor receptor (EGFR) … obtained from plasma,
which was serially collected at baseline, after 2 cycles of treatment, 2 cycles prior to the treatment …
which was serially collected at baseline, after 2 cycles of treatment, 2 cycles prior to the treatment …
LYTAC targeting galectin-1 to enhance radioimmunotherapy of cancers in the upper aerodigestive tract
Y Jiang, G Ahn, M Rahman, H Cao, C Bertozzi, Q Le - Cancer Research, 2024 - AACR
67 天前 - … oncoproteins such as epidermal growth factor receptor (EGFR) and … -derived
suppressor cells. Despite promising as an immune checkpoint target, effective anti-Gal-1 therapies …
suppressor cells. Despite promising as an immune checkpoint target, effective anti-Gal-1 therapies …